Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117414 · ClinicalTrials.gov registry record · NA
Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 275
- Enrollment target
NCT02117414 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 275 participants.
The verdict
NCT02117414, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
Study Summary
The purpose of the Evera MRI™ study is to confirm safety and efficacy of the Evera MRI ICD (Implantable cardioverter-defibrillator) System in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans without positioning restrictions (MRI scans may occur anywhere on the body).
Interventions
- DEVICE MRI scan sequences of the head and chest regions
- OTHER Waiting Period Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117414
The ClinicalTrials.gov registry entry for NCT02117414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI scan sequences of the head and chest regions is the first listed.
NCT02117414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02117414 about?
NCT02117414 is a clinical study titled "Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access". The purpose of the Evera MRI™ study is to confirm safety and efficacy of the Evera MRI ICD (Implantable cardioverter-defibrillator) System in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans without positioning restrictions (MRI scans may occur anywhere on th...
What is the current status of trial NCT02117414?
This trial is currently completed. It is a NA study. The enrollment target is 275 participants. The study started on 2014-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02117414?
The interventions under investigation include: MRI scan sequences of the head and chest regions (DEVICE), Waiting Period Visit (OTHER).
Who is sponsoring clinical trial NCT02117414?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.